CombiPatch Storage After Dispensing
No, CombiPatch does NOT require refrigeration after being dispensed to the patient. However, there appears to be confusion here—CombiPatch is an estradiol/norethindrone acetate transdermal patch, NOT a buprenorphine/naloxone product 1.
Critical Clarification
The question conflates two completely different medications:
- CombiPatch: estradiol/norethindrone acetate for hormone replacement therapy
- Buprenorphine/naloxone patches: used for opioid use disorder or pain management
These are entirely separate products with different storage requirements.
Storage Requirements for CombiPatch
CombiPatch should be stored in the refrigerator at 36°F to 46°F (2°C to 8°C) 1. This applies both before AND after dispensing to the patient. Key storage instructions include:
- Store systems in sealed foil pouches
- Keep refrigerated at all times
- Avoid areas where extreme temperatures can occur
- Keep out of reach of children
The FDA label explicitly states refrigeration is required for proper storage 1. This is not optional storage—it is the mandated storage condition to maintain product stability and efficacy.
Common Pitfall
Many transdermal patches do NOT require refrigeration after dispensing, which may cause confusion. However, CombiPatch is an exception due to the hormone formulation's stability requirements. Pharmacists must counsel patients that this patch needs continuous refrigeration at home, unlike many other transdermal systems.
If Asking About Buprenorphine Patches
If the actual question concerns buprenorphine transdermal patches (such as Butrans), these typically do NOT require refrigeration and can be stored at room temperature. The buprenorphine transdermal systems are stable at controlled room temperature and are designed for convenient home use without special storage requirements 2, 3.